Abstract
The Perindopril Protection against Recurrent Stroke Study (PROGRESS) grew out of discussions at a World Health Organization/International Society of Hypertension (WHO-ISH) meeting on Hypertension and Cerebrovascular disease held in Nara, Japan, in May 1993 [1].At the time, there was broad consensus that the benefits of blood pressure (BP) lowering were established for the primary prevention of stroke [2], but there was a clear need for further randomised trials to determine the role and possible benefits of BP lowering for the secondary prevention of stroke in patients who had survived a previous stroke as this remained an open question.
| Original language | English |
|---|---|
| Pages (from-to) | 617-621 |
| Number of pages | 5 |
| Journal | Cerebrovascular Diseases |
| Volume | 50 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - Dec 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Secondary stroke prevention
- ·Blood pressure lowering
- Perindopril and indapamide
- Asian and Caucasian participants
Fingerprint
Dive into the research topics of 'PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver